GENVEC INC

GAITHERSBURG, MD How do I update this listing?

Create Email Alert

Genvec is based out of Gaithersburg. Develops and commercializes novel therapies that produce medically beneficial proteins at the site of disease. The company applies its gene based technologies to create product candidates, such as TNFerade for the treatment of cancer, and BIOBYPASS, to treat severe coronary artery disease.Whalewisdom has at least 1 13G filings, and 106 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2010-01-28. The notice included securities offered of Equity

Contact Info

genvec inc
65 W WATKINS MILL RD
GAITHERSBURG MD    20878

Business Phone: 2406320740
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2010-01-28 D BIOTECHNOLOGY Equity 1,999,999 1,999,999 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
PAUL H. FISCHER subscription required
    DIRECTOR EXECUTIVE OFFICER
DOUGLAS J. SWIRSKY subscription required
    EXECUTIVE OFFICER
WAYNE T. HOCKMEYER subscription required
    DIRECTOR
ZOLA P. HOROVITZ subscription required
    DIRECTOR
WILLIAM N. KELLEY subscription required
    DIRECTOR
KEVIN M. ROONEY subscription required
    DIRECTOR
JOSHUA RUCH subscription required
    DIRECTOR
MARC SCHNEEBAUM subscription required
    DIRECTOR

Elevate your investments